134 related articles for article (PubMed ID: 67161)
21. Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma.
Raje N; Hideshima T; Davies FE; Chauhan D; Treon SP; Young G; Tai YT; Avigan D; Gong J; Schlossman RL; Richardson P; Kufe DW; Anderson KC
Br J Haematol; 2004 May; 125(3):343-52. PubMed ID: 15086415
[TBL] [Abstract][Full Text] [Related]
22. Characterization of antiserum against myeloma cells.
Cawley LP; Goodwin WL; Minard BJ
Cancer Res; 1973 Jan; 33(1):17-22. PubMed ID: 4629871
[No Abstract] [Full Text] [Related]
23. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
Martín P; Santón A; Bellas C
Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
[TBL] [Abstract][Full Text] [Related]
24. Antigenic characterization of murine rosette and plaque-forming cells.
Laskov R; Rabinowitz R; Schlesinger M
Immunology; 1973 Jun; 24(6):939-54. PubMed ID: 4123963
[TBL] [Abstract][Full Text] [Related]
25. Interaction between clonal plasma cells and the immune system in plasma cell dyscrasias.
Perez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Garcia-Marcos MA; Moreno I; Dominguez M; Galende J; Heras N; Gonzalez MI; San Miguel JF; Orfao A;
J Biol Regul Homeost Agents; 2004; 18(2):161-5. PubMed ID: 15471221
[TBL] [Abstract][Full Text] [Related]
26. Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras.
Schiff SE; Buckley RH
J Immunol; 1987 Apr; 138(7):2088-94. PubMed ID: 2881966
[TBL] [Abstract][Full Text] [Related]
27. [The immunological phenotype and proliferative activity of the tumor lymphocytes in multiple myeloma].
Golenkov AK; Nazarova IN; Sarycheva TG; Miterev GIu; Kozinets GI
Ter Arkh; 1993; 65(7):38-41. PubMed ID: 8211777
[TBL] [Abstract][Full Text] [Related]
28. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.
Westendorf JJ; Ahmann GJ; Armitage RJ; Spriggs MK; Lust JA; Greipp PR; Katzmann JA; Jelinek DF
J Immunol; 1994 Jan; 152(1):117-28. PubMed ID: 7504707
[TBL] [Abstract][Full Text] [Related]
29. Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients.
Cassel A; Leibovitz N; Hornstein L; Quitt M; Aghai E
Exp Hematol; 1990 Dec; 18(11):1171-3. PubMed ID: 2226677
[TBL] [Abstract][Full Text] [Related]
30. Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
Christensen O; Lupu A; Schmidt S; Condomines M; Belle S; Maier A; Hose D; Neuber B; Moos M; Kleist C; Terness P; Ho AD; Goldschmidt H; Klein B; Hundemer M
J Immunother; 2009; 32(6):613-21. PubMed ID: 19483648
[TBL] [Abstract][Full Text] [Related]
31. Purification and characterization of human bone marrow lymphocyte subpopulations: evidence for the existence of an alloreactive immature T cell.
Wulff JC; Held H; Mueller-Hermelink HK; Schlaak M
Clin Exp Immunol; 1981 Jun; 44(3):485-90. PubMed ID: 6459896
[TBL] [Abstract][Full Text] [Related]
32. Formation of cytotoxic lymphocytes in mixed leukocyte culture systems: introduction.
Cerottini JC; MacDonald HR; Brunner KT
Transplant Proc; 1973 Dec; 5(4):1621-4. PubMed ID: 4130070
[No Abstract] [Full Text] [Related]
33. Isolation of human lymphocyte antigens class I-restricted cytotoxic T lymphocytes against autologous myeloma cells.
Pellat-Deceunynck C; Jego G; Harousseau JL; Vié H; Bataille R
Clin Cancer Res; 1999 Mar; 5(3):705-9. PubMed ID: 10100725
[TBL] [Abstract][Full Text] [Related]
34. Autologous mixed lymphocyte reaction in multiple myeloma patients: effect of adherent mononuclear cells and T lymphocytes.
Lahat N; Aghai E; Quitt M; Froom P
Diagn Immunol; 1986; 4(2):75-80. PubMed ID: 2940046
[TBL] [Abstract][Full Text] [Related]
35. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.
Caligaris-Cappio F; Bergui L; Tesio L; Pizzolo G; Malavasi F; Chilosi M; Campana D; van Camp B; Janossy G
J Clin Invest; 1985 Sep; 76(3):1243-51. PubMed ID: 2931452
[TBL] [Abstract][Full Text] [Related]
36. The effect of anti-plasma cell serum on B cells.
Nariuchi H; Matuhasi T
J Immunol; 1974 Feb; 112(2):462-7. PubMed ID: 4205202
[No Abstract] [Full Text] [Related]
37. Antigens on human plasma cells identified by monoclonal antibodies.
Anderson KC; Park EK; Bates MP; Leonard RC; Hardy R; Schlossman SF; Nadler LM
J Immunol; 1983 Mar; 130(3):1132-8. PubMed ID: 6401780
[TBL] [Abstract][Full Text] [Related]
38. [Phenotypic analysis of myeloma cells].
Mihara K; Harada H; Kawano MM
Nihon Rinsho; 1995 Mar; 53(3):574-9. PubMed ID: 7699888
[TBL] [Abstract][Full Text] [Related]
39. [Monoclonal antibodies against myeloma cells].
Hata H; Matsuzaki H
Nihon Rinsho; 1995 Mar; 53(3):580-5. PubMed ID: 7699889
[TBL] [Abstract][Full Text] [Related]
40. Multiple myeloma: circulating lymphocytes that express plasma cell antigens.
Ruiz-Argüelles GJ; Katzmann JA; Greipp PR; Gonchoroff NJ; Garton JP; Kyle RA
Blood; 1984 Aug; 64(2):352-6. PubMed ID: 6611178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
